Sfoglia per AUTORE
GUPTA V
Collezione AOU Novara

  

Items : 3

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Nov 10;41(32):4993-5004. doi: 10.1200/JCO.22.01972. Epub 2023 Mar 7.

2023
AOU Novara

Kiladjian JJ; Cui J; Salama ME; Colak G; Wondergem MJ; Hoffman R; Somervaille TCP; Granacher N; Scandura JM; Talpaz M; Hobbs G; Mead AJ; Rampal RK; Passamonti F; Devos T; Palandri F; Patriarca A; Kremyanskaya M; Mascarenhas J; Vannucchi AM; Verstovsek S; Curto-García N; Harrison C; Gupta V;

Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2023 May 2;62(5):e147-e152. doi: 10.1093/rheumatology/keac603.

2023
AOU Città della Salute di Torino
AOU Novara

Agarwal V; Aggarwal R; Gupta L; Chinoy H; Loarce-Martos J; Prieto-González S; Gonzalez RA; Gil-Vila A; Sato S; Kimura N; Kaneko Y; Nakashima R; Yoshida A; Needham M; Srivastav N; Limaye V; Tomaras S; Langguth D; Hoff LS; Kusumo Wibowo SA; Traboco LS; Danielli MG; Venerito V; Sainaghi PP; Orsolini G; De Angelis R; Quartuccio L; Franceschini F; Sebastiani GD; et alii...

Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. in Future oncology (London, England) / Future Oncol. 2022 Sep;18(27):2987-2997. doi: 10.2217/fon-2022-0484. Epub 2022 Aug 11.

2022
AOU Novara

Harrison CN; Gupta VK; Gerds AT; Rampal R; Verstovsek S; Talpaz M; Kiladjian JJ; Mesa R; Kuykendall AT; Vannucchi AM; Palandri F; Grosicki S; Devos T; Jourdan E; Wondergem MJ; Al-Ali HK; Buxhofer-Ausch V; Alvarez-Larrán A; Patriarca A; Kremyanskaya M; Mead AJ; Akhani S; Sheikine Y; Colak G; Mascarenhas J;